This pharmacy business has operated continuously since 1994 and enjoys strong repeat business. A balanced mix of one-time projects and repeat engagements smooths revenue through the year and reduces seasonality risk. Performance has been consistent year over year, with the most recent period among the strongest in the company's history. The trade area is experiencing steady population and commercial growth, supporting long-term demand. A tenured team of 19 handles day-to-day operations; several key employees have been with the company for many years. The customer database numbers in the thousands and represents a valuable, largely untapped marketing asset. Standard operating procedures are documented, making training and quality control straightforward. The current owner works a normal full-time schedule and focuses on quoting, scheduling, and customer relationships. Under the same ownership since 1994, the company has weathered multiple economic cycles while maintaining profitability. The fundamentals are in place for a new owner to grow well beyond current levels.
Seller will carry 25% at 6% interest, 5-year note, for a well-qualified buyer.
Owner is scaling back for health-and-lifestyle reasons and will assist with a full transition.
Seller will provide 8 weeks of on-site training and transition support.
The business occupies a 2,970 sq ft commercial space; the space is well-maintained and fully equipped.
Few direct competitors offer the same breadth of services in the immediate market.
Expansion potential through a second location, added staff, and deeper penetration of nearby markets.
Modeling Healthcare business · $1.09M
Asking price is $1.09M. Type an offer or drag to model one.
SBA 7(a) acquisition loans typically require ~10% down.
SBA business-acquisition loans are usually 10 years.
A market salary for whoever runs the business day-to-day, subtracted from earnings to show true profit. Set to $0 if you will owner-operate.
Estimates for illustration only, based on the listed SDE and your assumptions. Closing costs are estimated at ~2.5% of price for fees and working capital. Actual loan terms, taxes, and earnings will differ. This is not financial advice. Verify all figures in diligence and consult qualified advisors.
Open the full Deal AnalyzerThe documents below open to qualified buyers in the secure data room after a signed NDA.
